SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.746
AS - Asia 5.118
EU - Europa 1.636
SA - Sud America 1.339
AF - Africa 154
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.489
SG - Singapore 2.154
BR - Brasile 1.019
CN - Cina 745
HK - Hong Kong 591
VN - Vietnam 537
IT - Italia 468
BD - Bangladesh 335
FI - Finlandia 227
RU - Federazione Russa 203
ID - Indonesia 179
JP - Giappone 176
FR - Francia 172
DE - Germania 151
GB - Regno Unito 136
IN - India 113
AR - Argentina 104
CA - Canada 101
MX - Messico 98
UA - Ucraina 58
CO - Colombia 56
NL - Olanda 53
TR - Turchia 51
ZA - Sudafrica 51
EC - Ecuador 50
AT - Austria 48
IQ - Iraq 40
CL - Cile 31
PK - Pakistan 28
PY - Paraguay 27
VE - Venezuela 27
SE - Svezia 25
ES - Italia 23
MA - Marocco 23
SA - Arabia Saudita 23
UZ - Uzbekistan 20
MY - Malesia 19
KE - Kenya 18
DZ - Algeria 15
JM - Giamaica 14
PH - Filippine 14
TN - Tunisia 13
AZ - Azerbaigian 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DO - Repubblica Dominicana 9
JO - Giordania 9
BO - Bolivia 8
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
NP - Nepal 8
PL - Polonia 8
AU - Australia 7
IE - Irlanda 7
UY - Uruguay 7
AL - Albania 6
BH - Bahrain 6
IL - Israele 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
HN - Honduras 5
KR - Corea 5
KZ - Kazakistan 5
SN - Senegal 5
BE - Belgio 4
OM - Oman 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
EE - Estonia 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 13.981
Salva come PNG Salva come JPEG
Città #
Singapore 1.123
Ashburn 781
Santa Clara 779
San Jose 738
Hong Kong 588
Fairfield 274
Council Bluffs 258
Beijing 251
Helsinki 219
Ho Chi Minh City 190
Tokyo 171
Chandler 165
Lauterbourg 148
New York 142
Jakarta 133
Hanoi 121
Houston 108
Woodbridge 103
São Paulo 82
Seattle 75
Wilmington 74
Princeton 72
Los Angeles 69
Mexico City 69
Dallas 67
Chicago 60
Cambridge 58
Moscow 56
Orem 48
Rome 48
San Diego 45
Nuremberg 42
London 41
Milan 41
Ann Arbor 40
Shanghai 40
Toronto 40
Rio de Janeiro 32
Buffalo 30
Haiphong 23
Salt Lake City 23
Vienna 23
Baghdad 22
Jacksonville 22
Belo Horizonte 21
Chennai 20
Da Nang 20
Quito 20
San Francisco 20
Curitiba 19
Montreal 19
Brooklyn 18
Guangzhou 18
Medellín 18
Porto Alegre 18
Tashkent 18
Brasília 17
Frankfurt am Main 17
Naples 17
Biên Hòa 16
Bologna 16
Falkenstein 16
Falls Church 16
Portsmouth 16
Ferrara 14
Nairobi 14
Atlanta 13
Caracas 13
Dhaka 13
Fortaleza 13
Guayaquil 13
Johannesburg 13
Manchester 13
Bari 12
Guarulhos 12
Istanbul 12
Mumbai 12
Buenos Aires 11
Turin 11
Amsterdam 10
Asunción 10
Campinas 10
Charlotte 10
Hangzhou 10
Salvador 10
Santiago 10
Tampa 10
Amman 9
Ankara 9
Baku 9
Hải Dương 9
Juiz de Fora 9
New Delhi 9
Phoenix 9
St Petersburg 9
Cagliari 8
Can Tho 8
Casablanca 8
Florence 8
Kuala Lumpur 8
Totale 8.275
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 175
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 172
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 169
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 157
The Immune Landscape of Cancer 150
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 146
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 138
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 137
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 133
Oncogenic Signaling Pathways in The Cancer Genome Atlas 133
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 130
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 119
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 118
ALPPS for primary and secondary liver tumors 115
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 113
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 109
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 108
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 107
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 107
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 105
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 104
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 103
Comprehensive Characterization of Cancer Driver Genes and Mutations 103
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 102
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 99
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 98
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 97
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 95
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 95
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 95
Pathogenic Germline Variants in 10,389 Adult Cancers 95
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 94
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 93
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 92
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 91
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 90
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 89
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 89
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 89
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 89
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 89
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 88
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 87
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 87
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 86
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 84
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 84
Primary leiomyoma of the liver in an immunocompetent patient 83
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 83
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 83
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 83
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 83
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 83
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 82
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 82
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 82
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 82
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 81
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 81
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 81
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 81
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 81
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 79
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 79
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 78
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 78
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 78
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years 77
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 77
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 77
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 77
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 76
Multicentre evaluation of case volume in minimally invasive hepatectomy 75
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 75
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 74
Outcome of Right Hepatectomies in Patients Older Than 70 Years 74
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 72
Long Term Follow-Up of Patients with De Novo Tumors after 1300 Liver Transplantations: A Case-Control Study 72
Efficacy of MELD score in predicting survival after liver retransplantation 71
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 71
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 71
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 70
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 70
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 70
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 69
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 69
The peculiar aging of human liver: A geroscience perspective within transplant context 68
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 68
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 67
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome 67
Is it time to develop a robotic difficulty score system? 67
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 67
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 67
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 66
Recommendations for management of patients with neuroendocrine liver metastases 65
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection 65
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 65
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 65
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 64
Totale 9.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20268.560 467 344 853 1.016 934 318 679 507 1.024 1.285 590 543
2026/2027191 191 0 0 0 0 0 0 0 0 0 0 0
Totale 14.525